TIAZAC
Growth will be higher in India in 2013 than 2012: Ellen Kullman, CEO, DuPontThere was hesitation in 2012 with rupee devaluation and some pullback on infra investment but we see a lot of opportunity in 2013, says Ell...- Sun Pharma receives USFDA nod for generic Clarinex, TiazacSun Pharma has received approval from USFDA for its abbreviated new drug application to market a generic version of Schering Plough's Clari...
- Load More